RASiACE inhibitorangiotensin II receptor blockerheart failureResidual left ventricular (LV) hypertrophy
…tion-to-treat analysis (RASi n=95; control n=99). At 12 months, RASi therapy was associated with a greater reduction in LVMI compare…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: angiotensin II receptor blocker ×
angiotensin II receptor blocker
This drug is selected. Its supporting articles are shown below.